מזומני החברה: silopharma.com (SILO)

Silo Pharma, Inc. (SILO) is a biopharmaceutical startup developing psychedelic treatments to combat Alzheimer's disease and depression. The current cash position demonstrates liquidity dynamics, where the parameter value equals 0.01. Business resilience is ensured by strict control over cold chain raw material supplies. The company's development relies on venture capital, remaining independent of general macroeconomic fluctuations.
פילוחים אנליטיים של חברת Silo Pharma, Inc.

Fundamental analysis requires separating real liquidity from accounting accruals to minimize investment risks. This is critical for Silo Pharma, Inc. (SILO), as the preclinical development of psilocybin drugs requires constant funding. This metric captures the actual cash balance in accounts, excluding "paper" profits. Analyzing the size of cash resources allows for an accurate calculation of the burn rate, which determines the viability of the pipeline before a cash crunch occurs.